PXAI Audio Feed
22/04 23:12 observer.com

Anne Wojcicki on 23andMe’s Second Life

23ANDMETECHNOLOGYBIOTECHECONOMYREGENERONJANET WOJCICKI
10/04 08:36 defenseworld.net

Sanford C. Bernstein Lowers Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $921.00

Regeneronprice targetSanford BernsteinBarclaysTruistbiopharma
09/04 09:06 defenseworld.net

Investment Analysts’ Weekly Ratings Updates for Regeneron Pharmaceuticals (REGN)

Regeneronanalyst ratingsprice targetoutperformbuyoverweight
05/04 12:33 defenseworld.net

2,145 Shares in Regeneron Pharmaceuticals, Inc. $REGN Acquired by Perpetual Ltd

RegeneronPerpetual Ltdinstitutional investmentSEC filingbiopharmaceuticalshare acquisition
02/04 21:30 investing.com

Regeneron says it expects to avoid new US pharma tariffs

RegeneronUS pharma tariffstrade policydrug pricingsupply chainbiologics
30/03 11:18 defenseworld.net

Regeneron Pharmaceuticals, Inc. $REGN Shares Acquired by Chesley Taft & Associates LLC

RegeneronChesley Taft13F filinginstitutional investmentbiopharmashare acquisition
24/03 19:25 defenseworld.net

Avanza Fonder AB Purchases 1,590 Shares of Regeneron Pharmaceuticals, Inc. $REGN

Avanza Fonder ABRegeneronQ4 13Fshare purchasebiopharmaNasdaq
17/03 10:50 defenseworld.net

California Public Employees Retirement System Sells 111,602 Shares of Regeneron Pharmaceuticals, Inc. $REGN

CalPERSRegeneron13F filingshare saleinvestor activitybiopharmaceutical
16/03 09:21 defenseworld.net

Alliancebernstein L.P. Sells 63,344 Shares of Regeneron Pharmaceuticals, Inc. $REGN

AlliancebernsteinRegeneron13F filinginstitutional investorshare salehedge fund
16/03 09:21 defenseworld.net

Alliancebernstein L.P. Sells 63,344 Shares of Regeneron Pharmaceuticals, Inc. $REGN

AlliancebernsteinRegeneron13F filinginstitutional investorshare salehedge fund
Comments
Loading...
0